Literature DB >> 16210588

The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules.

Tsufit Gonen-Gross1, Hagit Achdout, Tal I Arnon, Roi Gazit, Noam Stern, Václav Horejsí, Debra Goldman-Wohl, Simcha Yagel, Ofer Mandelboim.   

Abstract

For a proper development of the placenta, maternal NK cells should not attack the fetal extravillous cytotrophoblast cells. This inhibition of maternal NK cells is partially mediated via the nonclassical MHC class I molecule HLA-G. Recently, we demonstrated that HLA-G forms disulfide-linked high molecular complexes on the surface of transfected cells. In the present study, we demonstrate that HLA-G must associate with beta(2)m for its interaction with CD85J/leukocyte Ig-like receptor-1 (LIR-1). Although HLA-G free H chain complexes are expressed on the surface, they are not recognized and possibly interfere with CD85J/LIR-1 and HLA-G interaction. The formation of these complexes on the cell surface might represent a novel mechanism developed specifically by the HLA-G protein aimed to control the efficiency of the CD85J/LIR-1-mediated inhibition. We also show that endogenous HLA-G complexes are expressed on the cell surface. These findings provide novel insights into the delicate interaction between extravillous cytotrophoblast cells and NK cells in the decidua.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210588     DOI: 10.4049/jimmunol.175.8.4866

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

Review 1.  The multi-faceted nature of HLA class I dimer molecules.

Authors:  Elaine C Campbell; Antony N Antoniou; Simon J Powis
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

Review 2.  Stranger in a strange land.

Authors:  Joan S Hunt
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

3.  A bony fish immunological receptor of the NITR multigene family mediates allogeneic recognition.

Authors:  John P Cannon; Robert N Haire; Andrew T Magis; Donna D Eason; Kelley N Winfrey; Jose A Hernandez Prada; Kate M Bailey; Jean Jakoncic; Gary W Litman; David A Ostrov
Journal:  Immunity       Date:  2008-07-31       Impact factor: 31.745

4.  HLA-G dimer targets Granzyme B pathway to prolong human renal allograft survival.

Authors:  Ashwin Ajith; Vera Portik-Dobos; Anh Thu Nguyen-Lefebvre; Christine Callaway; Daniel D Horuzsko; Rajan Kapoor; Carlos Zayas; Katsumi Maenaka; Laura L Mulloy; Anatolij Horuzsko
Journal:  FASEB J       Date:  2019-01-08       Impact factor: 5.191

5.  Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma.

Authors:  Simon Jasinski-Bergner; Christine Stoehr; Juergen Bukur; Chiara Massa; Juliane Braun; Stefan Hüttelmaier; Verena Spath; Roland Wartenberg; Wolfgang Legal; Helge Taubert; Sven Wach; Bernd Wullich; Arndt Hartmann; Barbara Seliger
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

6.  HLA-F complex without peptide binds to MHC class I protein in the open conformer form.

Authors:  Jodie P Goodridge; Aura Burian; Ni Lee; Daniel E Geraghty
Journal:  J Immunol       Date:  2010-05-05       Impact factor: 5.422

7.  Conformation of human leucocyte antigen-C molecules at the surface of human trophoblast cells.

Authors:  Richard Apps; Lucy Gardner; Sue E Hiby; Andrew M Sharkey; Ashley Moffett
Journal:  Immunology       Date:  2008-01-18       Impact factor: 7.397

8.  Synthesis of beta(2)-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells.

Authors:  Pedro J Morales; Judith L Pace; Jeralyn Sue Platt; Daudi K Langat; Joan S Hunt
Journal:  Immunology       Date:  2007-05-02       Impact factor: 7.397

Review 9.  HLA-G: a human pregnancy-related immunomodulator.

Authors:  Joan S Hunt; Daudi L Langat
Journal:  Curr Opin Pharmacol       Date:  2009-06-29       Impact factor: 5.547

10.  Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric study.

Authors:  Isabela J Wastowski; Renata T Simões; Layale Yaghi; Eduardo A Donadi; João T Pancoto; Isabelle Poras; Emmanuèle Lechapt-Zalcman; Myriam Bernaudin; Samuel Valable; Carlos G Carlotti; Sébastien Flajollet; Stine S Jensen; Soldano Ferrone; Edgardo D Carosella; Bjarne W Kristensen; Philippe Moreau
Journal:  Am J Pathol       Date:  2012-12-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.